Current evidence is synthesized on how exosomal ncRNAs orchestrate immune-metabolic networks that shape TNBC evolution and their emerging clinical applications as liquid biopsy biomarkers for diagnosis, prognostic stratification, and therapeutic monitoring, as well as their potential as therapeutic targets via antisense oligonucleotides (ASOs), antagomirs, and engineered exosome-based delivery platforms.
Hui-Xin Chen, Rong Luo, Jiakang Ma et al.· Cancer Biome and Targeted Th...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.